Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

Delayed Data
As of 4:01pm ET
 -0.14 / -0.12%
Today’s Change
Today|||52-Week Range
Clorox, Consumer Products Should Shine Amid Jobs Slowdown, Cramer Says
12:53pm / TheStreet.com
Drug Stocks Q1 Earnings Preview: AEGR, AERI, MACK, PRTA
Apr 29 / Zacks.com
Solid Q1 Earnings Fail to Boost Pharma ETFs
11:53am / Zacks.com
Celgene Corporation Short-Term, Long-Term Guidance Up. Medium-Term? Not So Much
Apr 28 / MotleyFool.com
Drug Stocks' Earnings Previews: FGEN, IRWD, ENTA, FLML
11:04am / Zacks.com
Sanofi's Bid for Medivation Is Too Low
Apr 28 / MotleyFool.com
Geron (GERN) Q1 Loss In-Line, Imetelstat Remains in Focus
8:55am / Zacks.com
The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, Novartis, Baxalta Incor...
Apr 28 / Zacks.com
Merck (MRK) Raises Outlook Following Q1 Earnings Beat
May 05 / Zacks.com
Why Johnson & Johnson Is So Optimistic These Days
Apr 28 / MotleyFool.com
Jim Cramer's 'Mad Money' Recap: Don't Freak Out
May 04 / TheStreet.com
Drug Stocks' Earnings Previews: KERX, BXLT, BMRN, AGEN, IMGN
Apr 27 / Zacks.com
Drug Stocks Earnings Preview: GERN, RPRX, ICPT, AGIO & More
May 04 / Zacks.com
Don't get too used to a weak dollar
Apr 27 / CNNMoney.com
Cramer: Market Rotation Is Happening
May 04 / TheStreet.com
J&J's Q1 Results Suggest More Upside for Medivation, Inc.
Apr 27 / MotleyFool.com
Bank of America's 17 High-Quality Cash-Rich Stocks for Investors to Consider
May 04 / TheStreet.com
S&P strips ExxonMobil of coveted triple A rating
Apr 26 / FT.com
3 Great Dividend Stocks for Retirees
May 04 / MotleyFool.com
ExxonMobil loses perfect AAA rating after 67 years
Apr 26 / CNNMoney.com
Baby Powder Cancer Suits Cloud Johnson and Johnson
May 03 / Zacks.com
Lilly (LLY) Raises View despite Q1 Earnings & Revenue Miss
Apr 26 / Zacks.com
Should You Listen to Warren Buffett?
May 03 / Zacks.com
Worried About Social Security? Buy These 4 Stocks
Apr 26 / MotleyFool.com
3 Stocks to Buy in a Market Crash
May 03 / MotleyFool.com
Big Food in health drive to keep market share
Apr 25 / FT.com
Aduro (ADRO) Q1 Loss Wider than Expected, Revenues Fall
May 03 / Zacks.com
3 Data Points That Will Likely Define Amgen's First-Quarter Report on April 28
Apr 25 / MotleyFool.com
 Johnson & Johnson loses second cancer lawsuit
May 03 / CNNMoney.com
The Zacks Analyst Blog Highlights: Walt Disney, Goldman Sachs Group, Johnson & Johnso...
Apr 25 / Zacks.com
Johnson & Johnson (JNJ) Stock Drops, Must Pay $55 Million in Talc-Powder Case
May 03 / TheStreet.com
Global health scares spur scientific innovation
Apr 24 / FT.com
Geron (GERN) Q1 Earnings: What's in Store for the Stock?
May 03 / Zacks.com
Experimental Ebola vaccines need testing
Apr 24 / FT.com
Pfizer's (PFE) Stock Gains in Pre-Market on Q1 Earnings Beat
May 03 / Zacks.com
Race for universal flu vaccine gathers pace
Apr 24 / FT.com
Aside From 1 Eyesore, Amgen Delivers Another Solid Quarter
May 02 / MotleyFool.com
Are These 3 Biotechs Destined to Be Bought Out?
Apr 24 / MotleyFool.com
Better Buy: Intuitive Surgical, Inc. vs. Johnson & Johnson
May 02 / MotleyFool.com
Competitors Take Aim at Intuitive Surgical, Inc.
Apr 24 / MotleyFool.com
The Zacks Analyst Blog Highlights: Amgen, Johnson & Johnson, Pfizer, Mylan and Mallin...
May 02 / Zacks.com
Procter & Gamble Just Issued Its Smallest Dividend Hike in a Generation -- Here's Wha...
Apr 22 / MotleyFool.com
CAT, IBM, KO: Jim Cramer's Views
May 02 / TheStreet.com
AbbVie (ABBV) Likely to Beat on Q1 Earnings: Stock to Gain?
Apr 22 / Zacks.com
If Oil Goes Up, Buy Chevron, Not Exxon - Jim Cramer
Apr 29 / TheStreet.com
Dow 30 Stock Roundup: IBM, AmEx, Coke, JNJ Beat, Verizon Disappoints
Apr 22 / Zacks.com
3 Drug Stocks Reporting Early Next Week: PFE, MYL, MNK
Apr 29 / Zacks.com
What Awaits Healthcare Stocks ESRX and EPZM in Q1 Earnings?
Apr 22 / Zacks.com
Zacks Investment Ideas feature highlights: Visa, Johnson & Johnson and Snap-On Incorp...
Apr 29 / Zacks.com
Novartis (NVS) Q1 Earnings Miss; Gleevec Hit by Generics
Apr 22 / Zacks.com